Spinal and supraspinal mechanisms of neuropathic pain

Annals of the New York Academy of Sciences

Volumn 909, Issue , 2000, Pages 12-24

  Ossipov, Michael H ^a   Lai, Josephine ^a   Malan Jr , T Philip ^a   Porreca, Frank ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; DIZOCILPINE; DYNORPHIN A; GLUTAMIC ACID; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; OPIATE; OPIATE RECEPTOR; RESINIFERATOXIN;

AFFERENT NERVE GROUP 1; ALLODYNIA; BETA NERVE FIBER; CHRONIC PAIN; CONFERENCE PAPER; FACILITATION; HUMAN; HYPERALGESIA; NERVE FIBER C;

EID: 0033913077     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06673.x     Document Type: Conference Paper

References (56)

1. 1. ANONYMOUS. 1995. NIH Guide 24: 15.
2. 2. PAYNE, R. 1986. Neuropathic pain syndromes, with special reference to causalgia and reflex sympathetic dystrophy. Clin. J. Pain 2: 59-73.
3. 3. LEE, Y.W., S.R. CHAPLAN & T.L. YAKSH. 1995. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci. Lett. 199: 111-114.
4. 4. BIAN, D., M.L. NICHOLS, M.H. OSSIPOV, et al. 1995. Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. NeuroReport 6: 1981-1984.
5. 5. WEGERT, S., M.H. OSSIPOV, M.L. NICHOLS, et al. 1997. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats. Pain 71: 57-64.
6. 6. MAO, J., D.D. PRICE & D.J. MAYER. 1995. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 61: 353-364.
7. 7. MAO, J., D.D. PRICE & D.J. MAYER. 1995. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62: 259-274.
8. 8. YAMAMOTO, T. & T.L. YAKSH. 1992. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci. Lett. 135: 67-70.
9. 9. YEOMANS, D.C. & H.K. PROUDFIT. 1996. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence. Pain 68: 141-150.
10. 10. OSSIPOV, M.H., D. BIAN, T.P. MALAN, JR., et al. 1999. Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain 79: 127-133.
11. 11. BESSE, D., M.C. LOMBARD, J. M. ZAJAC, et al. 1990. Pre-and postsynaptic location of mu, delta and kappa opioid receptors in the superficial layers of the dorsal horn of the rat spinal cord. Prog. Clin. Biol. Res. 328: 183-186.
12. 12. CARROLL, J.A., J.S. SHAW & A.D. WICKENDEN. 1988. The physiological relevance of low agonist affinity binding at opioid mu-receptors. Br. J. Pharmacol. 94: 625-631.
13. 13. SHAW, J.S., J.D. ROURKE & K.M. BURNS. 1988. Differential sensitivity of antinociceptive tests to opioid agonists and partial agonists. Br. J. Pharmacol. 95: 578-584.
14. 14. OSSIPOV, M.H., Y. LOPEZ, M.L. NICHOLS, et al. 1995. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury. Neurosci. Lett. 199: 83-86.
15. 15. PORRECA, F., Q.B. TANG, D. BIAN, et al. 1998. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. Brain Res. 795: 197-203
16. 16. SWETT, J.E. & C.J. WOOLF. 1985. The somatotopic organization of primary afferent terminals in the superficial laminae of the dorsal horn of the rat spinal cord. J. Comp. Neurol. 231: 66-77.
17. 17. MALAN, T.P., M.H. OSSIPOV, L.R. GARDELL, et al. 1999. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain. In press.
18. 18. SUNG, B., H.S. NA, Y.I. KIM, et al. 1998. Supraspinal involvement in the production of mechanical allodynia by spinal nerve injury in rats. Neurosci. Lett. 246: 117-119.
19. 19. OSSIPOV, M.H., C.J. KOVELOWSKI, H. WHEELER-ACETO, et al. 1996. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone. J. Pharmacol. Exp. Ther. 277: 784-788.
20. 20. LEMAIRE, S., C. ROGERS, M. DUMONT, et al. 1995. Histogranin, a modified histone H4 fragment endowed with N-methyl-D-aspartate antagonist and immunostimulatory activities. Life Sci. 56: 1233-1241.
21. 21. FADEN, A.I. & T.P. JACOBS. 1984. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action. Br. J. Pharmacol. 81: 271-276.
22. 22. STEVENS, C.W., M.B. WEINGER & T.L. YAKSH. 1987. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats. Eur. J. Pharmacol. 138: 299-302.
23. 23. PRZEWLOCKI, R., L. STALA, M. GRECZEK, et al. 1983. Analgesic effects of mu-, delta-and kappa-opiate agonists and, in particular, dynorphin at the spinal level. Life Sci. 33: 649-652.
24. (1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism. J. Neurosci. 10: 3793-3800.
25. 25. BAKSHI, R. & A.I. FADEN. 1990. Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis. Brain Res. 507: 1-5.
26. 26. LONG, J.B., D.D. RIGAMONTI, M.A. OLESHANSKY, et al. 1994. Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury. J. Pharmacol. Exp. Ther. 269: 358-366.
27. 27. LONG, J.B. & P. SKOLNICK. 1994. 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury. Eur. J. Pharmacol. 261: 295-301.
28. 28. VANDERAH, T.W., T. LAUGHLIN, J.M. LASHBROOK, et al. 1996. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain 68: 275-281.
29. 29. CHEN, L., Y. GU & L.Y. HUANG. 1995. The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J. Physiol. (Lond.) 482: 575-581.
30. 30. LAI, S.L., Y. GU & L.Y. HUANG. 1998. Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons. Neurosci. Lett. 247: 115-118.
31. 31. TANG, Q., R. GANDHOKE, A. BURRITT, et al. 1999. High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors. J. Pharmacol. Exp. Ther. 291: 760-765.
32. 32. TANG, Q., R. GANDHOKE, R.M. LYNCH, et al. 1999. Dynorphin A mediates an increase in intracellular calcium in cultured neurons via a non-opioid, non-NMDA mechanism. J. Neurophysiol. In press.
33. (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain 69: 317-322.
34. 34. BIAN, D., M.H. OSSIPOV, M. IBRAHIM, et al. 1999. Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum. Brain Res 831: 55-63.
35. 35. OSSIPOV, M.H., Y. LOPEZ, M.L. NICHOLS, et al. 1995. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci. Lett. 199: 87-90.
36. 36. WAGNER, R. & J.A. DELEO. 1996. Pre-emptive dynorphin and N-methyl-D-aspartate glutamate receptor antagonism alters spinal immunocytochemistry but not allodynia following complete peripheral nerve injury. Neuroscience 72: 527-534.
37. 37. PERTOVAARA, A. 1998. A neuronal correlate of secondary hyperalgesia in the rat spinal dorsal horn is submodality selective and facilitated by supraspinal influence. Exp. Neurol. 149: 193-202.
38. 38. BIAN, D., M.H. OSSIPOV, C. ZHONG, et al. 1998. Tactile allodynia, but not thermal hyperalgesia, of the hindlimbs is blocked by spinal transection in rats with nerve injury. Neurosci. Lett. 241: 79-82.
39. 39. WILLIS, W.D. & K.N. WESTLUND. 1997. Neuroanatomy of the pain system and of the pathways that modulate pain. J. Clin. Neurophysiol. 14: 2-31.
40. 40. WILLIS, W.D., E.D. AL-CHAER, M.J. QUAST, et al. 1999. A visceral pain pathway in the dorsal column of the spinal cord. Proc. Natl. Acad. Sci. USA 96: 7675-7679.
41. 41. YAKSH, T.L., J.C. YEUNG & T.A. RUDY. 1976. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray. Brain Res. 114: 83-103.
42. 42. YAKSH, T.L. & T.A. RUDY. 1978. Narcotic analgesics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain 4: 299-359.
43. 43. LEWIS, V.A. & G.F. GEBHART. 1977. Evaluation of the periaqueductal central gray (PAG) as a morphine-specific locus of action and examination of morphine-induced and stimulation-produced analgesia at coincident PAG loci. Brain Res. 124: 283-303.
44. 44. LEWIS, V.A. & G.F. GEBHART. 1977. Morphine-induced and stimulation-produced analgesias at coincident periaqueductal central gray loci: evaluation of analgesic congruence, tolerance, and cross-tolerance. Exp. Neurol. 57: 934-955.
45. 45. BENNETT, G.J. & D.J. MAYER. 1979. Inhibition of spinal cord interneurons by narcotic microinjection and focal electrical stimulation in the periaqueductal central gray matter. Brain Res. 172: 243-257.
46. 46. JENSEN, T.S. & T.L. YAKSH. 1986. Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat. Brain Res. 363: 99-113.
47. 47. BASBAUM, A.I. & H.L. FIELDS. 1979. The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat: further studies on the anatomy of pain modulation. J. Comp. Neurol. 187: 513-531.
48. 48. BASBAUM, A.I., C.H. CLANTON & H.L. FIELDS. 1978. Three bulbospinal pathways from the rostral medulla of the cat: an autoradiographic study of pain modulating systems. J. Comp. Neurol. 178: 209-224.
49. 49. FIELDS, H.L., J. BRY, I. HENTALL, et al. 1983. The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J. Neurosci. 3: 2545-2552.
50. 50. FIELDS, H.L., M.M. HEINRICHER & P. MASON. 1991. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 14: 219-245.
51. 51. FIELDS, H.L. & M.M. HEINRICHER. 1989. Brainstem modulation of nociceptor-driven withdrawal reflexes. Ann. N.Y. Acad. Sci. 563: 34-44.
52. 52. FIELDS, H.L. & M.M. HEINRICHER. 1985. Anatomy and physiology of a nociceptive modulatory system. Philos. Trans. R Soc. Lond. B Biol. Sci. 308: 361-374.
53. 53. MORGAN, M.M. & H.L. FIELDS. 1994. Pronounced changes in the activity of nociceptive modulatory neurons in the rostral ventromedial medulla in response to prolonged thermal noxious stimuli. J. Neurophysiol. 72: 1161-1170.
54. 54. HEINRICHER, M.M. & S. MCGARAUGHTY. 1998. Analysis of excitatory amino acid transmission within the rostral ventromedial. Pain 75: 247-255.
55. 55. PERTOVAARA, A., H. WEI & M.M. HAMALAINEN. 1996. Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats. Neurosci. Lett. 218: 127-130.
56. 56. KOVELOWSKI, C.J., M.H. OSSIPOV, J. LAI, et al. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat. Pain. Submitted.